$4.75
-0.11-2.26%
At close: Aug 21, 5:00 PM EST
$4.58
-0.28-5.8%
Pre-Market: 7:03 AM EST
Intensity Therapeutics Inc Earnings Estimates
INTSNASDAQ
Intensity Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:INTS
Intensity Therapeutics (INTS) is scheduled to report Q3 earnings on November 5, 2026. Analysts estimate EPS of $-0.77 and quarterly revenue of N/A.
In the most recent quarter (Q2), Intensity Therapeutics reported EPS of $-1.11, missing estimates of $-0.78 by 0.42%. Revenue came in at $0, meeting the estimate of $0 by 0%.
Over the last 4 quarters, Intensity Therapeutics has averaged an EPS surprise of 0.15% and a revenue surprise of 0%.
Earnings Date
Nov 5
EPS Estimate
$-0.770
Quarterly Revenue Estimate
–
Annual Revenue
–
as of Jun 30
Intensity Therapeutics Earnings History
Analyze the earnings history of Intensity Therapeutics using advanced sorting and filters.
Intensity Therapeutics (INTS) Earnings Per Share
The chart below shows Intensity Therapeutics's reported EPS compared to analyst estimates over recent quarters.
Intensity Therapeutics (INTS) Revenue
The chart below shows Intensity Therapeutics's reported revenue compared to analyst estimates over recent quarters.
FAQ
When is Intensity Therapeutics (NASDAQ:INTS) reporting earnings?
Intensity Therapeutics (INTS) is scheduled to report earnings on November 5, 2026. The last reported earnings were for reported on August 11, 2026 for Q2.
What were the latest earnings per share (EPS) for Intensity Therapeutics (NASDAQ:INTS)?
The Actual EPS was $-1.11, which missed the estimate of $-0.78.
What were Intensity Therapeutics’s (NASDAQ:INTS) revenues?
The Actual Revenue was $0, which hit the estimate of $0.
